Acetic Acid → HCID 53638350, compound
Reaction equation
[NH2:1][C:2]1[CH:3]=[C:4]([CH:26]=[CH:27][C:28]=1[C:29]#[N:30])[CH2:5][N:6]1[C:11](=[O:12])[CH2:10][N:9]([C:13](=[O:22])[CH2:14][O:15][C:16]2[S:17][C:18]([Cl:21])=[CH:19][CH:20]=2)[CH2:8][CH:7]1[C:23]([OH:25])=[O:24].[N:31]1C=NC=N[CH:32]=1.CC(O)=O>CCO>[NH2:30][C:29]1[C:28]2[C:2](=[CH:3][C:4]([CH2:5][N:6]3[C:11](=[O:12])[CH2:10][N:9]([C:13](=[O:22])[CH2:14][O:15][C:16]4[S:17][C:18]([Cl:21])=[CH:19][CH:20]=4)[CH2:8][CH:7]3[C:23]([OH:25])=[O:24])=[CH:26][CH:27]=2)[N:1]=[CH:32][N:31]=1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution containing (+/−)-1-(3-amino-4-cyano-benzyl)-4-[(5-chloro-thiophen-2-yloxy)-acetyl]-6-oxo-piperazine-2-carboxylic acid (20 mg, 0.03 mmol), 1,3,5-triazine (28 mg, 0.34 mmol), and glacial HOAc (20 mg, 0.34 mmol) in absolute EtOH (6 mL) is maintained at reflux for 16 hours. The reaction mixture is concentrated to dryness and then purified by reverse-phase HPLC [Buffer A: water w/0.1% TFA; Buffer B: CH3CN w/0.1% TFA; Gradient: 0% B to 60% B over 30 min] to provide 15 mg (75%) of the title compound as a white solid. 1H NMR (300 MHz, d6-DMSO) δ3.75-4.38 (m, 5H), 4.67 (d, J=14.8 Hz, 1H), 4.79 (d, J=15.3 Hz, 1H), 4.95 (m, 1H), 5.09 (br d, J=16.0 Hz, 1H), 6.18 (m, 1H), 6.71 (m, 1H), 7.64 (m, 2H), 8.31 (d, J=8.5 Hz, 1H), 8.75 (s, 1H), 9.64 (br s, 2H) ppm; MS (ISP loop): m/z 476 (M+H).
Workup
- temperatureis maintained
- temperatureat reflux for 16 hours
- concentrationThe reaction mixture is concentrated to dryness
- custompurified by reverse-phase HPLC [Buffer A: water
Sources & evidence
- ORD record
- ord-1b9f067ec81446b88445157a37ebc9ea
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07612075B2
Reaction notes
Loading…